BRIACELL THERAPEUTICS CORP's ticker is BCTX and the CUSIP is 10778Y302. A total of 24 filers reported holding BRIACELL THERAPEUTICS CORP in Q4 2022. The put-call ratio across all filers is 0.04 and the average weighting 0.3%.
Quarter-by-quarter ownership
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynwood Capital Management Inc. | 1,583,878 | $10,168,497 | 12.88% |
| Redmond Asset Management, LLC | 137,689 | $883,963 | 0.29% |
| K.J. Harrison & Partners Inc | 34,640 | $216,891 | 0.04% |
| WASATCH ADVISORS LP | 612,088 | $3,929,605 | 0.02% |
| Concord Wealth Partners | 15,275 | $98,066 | 0.02% |
| Caption Management, LLC | 100,000 | $642,000 | 0.01% |
| Summit Trail Advisors, LLC | 35,000 | $224,700 | 0.01% |
| NATIXIS | 90,250 | $579,405 | 0.01% |
| TD Waterhouse Canada Inc. | 12,050 | $90,346 | 0.00% |
| SIMPLEX TRADING, LLC | 39,521 | $253 | 0.00% |